Additionally, a non-pathogenic recombinant T
Hussein and collaborators recently reported lowered levels of IGF-1 in the skin and blood of vitiligo patients compared to reference samples, confirming the systemic nature of vitiligo (El-Komy et al., 2023)
What to know about MariTide, Amgens experimental GLP-1 drug (NewsNation) GLP-1 drugs continue to reshape the health landscape, with the latest development focusing on treatments that could be taken monthly instead of weekly
Documentation and handling notes Documentation Antioxidant research compound listings should be reviewed alongside the product specification, pack size, stock status, and any available quality files
The FDA has responded with three waves of enforcement letters - September 2025, March 2026, and June 2026 - targeting telehealth companies for misleading GLP-1 marketing
In research models the two molecules act on parallel pathways of the growth hormone axis